Compare OSS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSS | EOLS |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 408.4M | 407.0M |
| IPO Year | 2017 | 2018 |
| Metric | OSS | EOLS |
|---|---|---|
| Price | $16.20 | $7.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $10.00 | ★ $15.50 |
| AVG Volume (30 Days) | ★ 1.3M | 710.6K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 133.85 | 1.23 |
| EPS | ★ N/A | N/A |
| Revenue | $37,027,382.00 | ★ $297,176,000.00 |
| Revenue This Year | $22.19 | $13.27 |
| Revenue Next Year | $20.67 | $17.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 34.46 | 11.61 |
| 52 Week Low | $3.46 | $3.86 |
| 52 Week High | $20.88 | $10.20 |
| Indicator | OSS | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 65.39 |
| Support Level | $14.48 | $5.95 |
| Resistance Level | $17.33 | $7.36 |
| Average True Range (ATR) | 1.54 | 0.34 |
| MACD | -0.35 | 0.00 |
| Stochastic Oscillator | 23.44 | 96.67 |
One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.